Earnest Partners LLC Myriad Genetics Inc Transaction History

Earnest Partners LLC

$22.1 Billion
Q3 2024

A detailed history of Earnest Partners LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Earnest Partners LLC holds 3,955,948 shares of MYGN stock, worth $52.9 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

3,955,948

Previous 4,072,018 2.85%

Holding current value

$52.9 Million

Previous $99.6 Million 8.71%

% of portfolio

0.49%

Previous 0.48%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$23.97 - $28.6 $2.78 Million - $3.32 Million	-116,070 Reduced 2.85%	3,955,948 $108 Million
Q2 2024 Aug 14, 2024	BUY	$17.98 - $25.47 $2.5 Million - $3.54 Million	138,960 Added 3.53%	4,072,018 $99.6 Million
Q1 2024 May 15, 2024	BUY	$17.59 - $23.59 $336,760 - $451,630	19,145 Added 0.49%	3,933,058 $83.9 Million
Q4 2023 Feb 14, 2024	BUY	$13.91 - $21.32 $6.13 Million - $9.39 Million	440,632 Added 12.69%	3,913,913 $74.9 Million
Q3 2023 Nov 14, 2023	BUY	$15.99 - $23.22 $3.51 Million - $5.1 Million	219,503 Added 6.75%	3,473,281 $55.7 Million
Q2 2023 Aug 07, 2023	BUY	$17.56 - $23.76 $3.39 Million - $4.58 Million	192,940 Added 6.3%	3,253,778 $75.4 Million
Q1 2023 May 15, 2023	SELL	$15.26 - $23.75 $3.72 Million - $5.79 Million	-243,618 Reduced 7.37%	3,060,838 $71.1 Million
Q4 2022 Feb 14, 2023	SELL	$14.51 - $20.99 $47.4 Million - $68.6 Million	-3,265,946 Reduced 49.71%	3,304,456 $47.9 Million
Q3 2022 Nov 14, 2022	BUY	$18.21 - $27.88 $1.97 Million - $3.02 Million	108,264 Added 1.68%	6,570,402 $125 Million
Q2 2022 Aug 12, 2022	BUY	$16.45 - $25.88 $3.04 Million - $4.79 Million	185,078 Added 2.95%	6,462,138 $117 Million
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $891,044 - $1.1 Million	-39,305 Reduced 0.62%	6,277,060 $158 Million
Q4 2021 Feb 07, 2022	BUY	$24.13 - $32.63 $1.56 Million - $2.11 Million	64,554 Added 1.03%	6,316,365 $174 Million
Q3 2021 Nov 15, 2021	BUY	$29.97 - $36.66 $1.75 Million - $2.14 Million	58,332 Added 0.94%	6,251,811 $202 Million
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $25.2 Million - $32.3 Million	-991,871 Reduced 13.8%	6,193,479 $189 Million
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $9.04 Million - $14.3 Million	453,921 Added 6.74%	7,185,350 $219 Million
Q4 2020 Feb 16, 2021	BUY	$12.16 - $19.77 $21.7 Million - $35.3 Million	1,785,819 Added 36.11%	6,731,429 $133 Million
Q3 2020 Nov 16, 2020	BUY	$11.25 - $14.75 $2.08 Million - $2.72 Million	184,528 Added 3.88%	4,945,610 $64.5 Million
Q2 2020 Aug 13, 2020	BUY	$10.69 - $16.49 $6.42 Million - $9.91 Million	600,798 Added 14.44%	4,761,082 $54 Million
Q1 2020 May 14, 2020	BUY	$9.78 - $29.53 $5.49 Million - $16.6 Million	561,534 Added 15.6%	4,160,284 $59.5 Million
Q4 2019 Feb 07, 2020	BUY	$20.93 - $35.1 $4.41 Million - $7.39 Million	210,501 Added 6.21%	3,598,750 $98 Million
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $74.8 Million - $160 Million	3,388,249 New	3,388,249 $97 Million

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Earnest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Earnest Partners LLC with notifications on news.

Account

Earnest Partners LLC Myriad Genetics Inc Transaction History